Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
  • AI
  • Tech
  • Cybersecurity
  • Finance
  • DeFi & Blockchain
  • Startups
  • Gaming
Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
Dataconomy
No Result
View All Result

Sam Altman co-founds Merge Labs to rival Neuralink

Merge Labs is currently being established, with an anticipated valuation of $850 million.

byKerem Gülen
August 13, 2025
in Industry
Home Industry
Share on FacebookShare on TwitterShare on LinkedInShare on WhatsAppShare on e-mail

According to Financial Times, Sam Altman is co-founding Merge Labs, a brain-to-computer interface startup, seeking funding potentially from OpenAI’s ventures team, to compete with Elon Musk’s Neuralink.

Merge Labs is currently being established, with an anticipated valuation of $850 million. Sources indicate that discussions regarding funding are in preliminary stages, and OpenAI has not yet finalized its participation. The terms of this potential investment remain subject to change as negotiations proceed. This new venture aims to develop technologies that facilitate direct interaction between the human brain and computer systems.

In addition to seeking capital, Merge Labs is reportedly collaborating with Alex Blania, who leads Tools for Humanity. Tools for Humanity, previously known as World, manages Altman’s digital identity project that utilizes eye-scanning technology. This project is designed to enable individuals to verify their human identity through a unique digital signature derived from their biometric data. The involvement of Tools for Humanity suggests a potential integration of identity verification or biometric security into Merge Labs’ brain-to-computer interface functionalities.

Stay Ahead of the Curve!

Don't miss out on the latest insights, trends, and analysis in the world of data, technology, and startups. Subscribe to our newsletter and get exclusive content delivered straight to your inbox.

Merge Labs will enter a competitive landscape, directly challenging Elon Musk’s Neuralink. Neuralink, founded by Musk in 2016 and publicly known since 2017, focuses on developing implantable computer interface chips for direct brain integration. Neuralink has advanced to human trials, specifically working with individuals experiencing severe paralysis. The company’s primary objective in these trials is to enable participants to control external devices solely through their thoughts, thereby restoring a degree of functional independence. Neuralink recently secured significant investment, raising $600 million in a Series E funding round in June, which valued the company at $9 billion.

The concept of “The Merge” has been a topic of discussion among technology leaders, including Sam Altman, who blogged about it in 2017. At that time, Altman postulated that humanity was already beginning to integrate with technology, stating, “Although the merge has already begun, it’s going to get a lot weirder. We will be the first species ever to design our own descendants.” This statement referenced research observed at OpenAI during a period when Elon Musk was still a co-founder of the organization. Musk departed from OpenAI in 2018. The relationship between Altman and Musk has since deteriorated, evidenced by recent public disagreements on the social media platform X, where Altman accused Musk of manipulation and Musk responded by labeling Altman as dishonest.


Featured image credit

Tags: merge labsneuralinksam altman

Related Posts

Snowflake to integrate Anthropic’s Claude Sonnet models

Snowflake to integrate Anthropic’s Claude Sonnet models

December 4, 2025
OpenAI Foundation awards .5M to over 200 nonprofits

OpenAI Foundation awards $40.5M to over 200 nonprofits

December 4, 2025
Alan Dye leaves Apple for Meta’s Reality Labs Studio

Alan Dye leaves Apple for Meta’s Reality Labs Studio

December 4, 2025
How professionals avoid information overload and make confident decisions

How professionals avoid information overload and make confident decisions

December 3, 2025
AWS re:Invent 2025: Day 1-3 announcements in a nutshell

AWS re:Invent 2025: Day 1-3 announcements in a nutshell

December 3, 2025
Anthropic hires legal heavyweights for a potential 2026 IPO

Anthropic hires legal heavyweights for a potential 2026 IPO

December 3, 2025

LATEST NEWS

Apple’s App Store winners show AI is now just a hidden feature

Uber launches robotaxi service in Dallas with Avride fleet

These are Google’s favorite Chrome extensions in 2025

Superhuman’s AI email tools are now everywhere in your inbox

Get Amazon Music Unlimited for free for three months

WordPress launches Telex AI to vibe code custom blocks

Dataconomy

COPYRIGHT © DATACONOMY MEDIA GMBH, ALL RIGHTS RESERVED.

  • About
  • Imprint
  • Contact
  • Legal & Privacy

Follow Us

  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
No Result
View All Result
Subscribe

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Policy.